Cervical Cancer Screening in Patients with Total Hysterectomy in a Diagnostic Center at Mexico City

Carlos Manuel Ortiz‑Mendoza


Background: The aim of this study was to outline the Pap smears rate done in women with total hysterectomy, sent to an urban diagnostic center that attends Mexican Government workers in the Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado (ISSSTE: State´s Employees´ Social Security and Social Services Institute) at Mexico City. Methods: It was a retrospective study on Pap smear reports taken in 2017. The reports came from users of four family medicine clinics and a general hospital´s gynecology service. Demographic facts, instruments for collection, kind of insurance (ISSSTE‑insurance or non‑insurance), and total hysterectomy history were evaluated. Results: From 4989 reports, 600 (12%) had a total hysterectomy history. In the patients with ISSSTE‑insurance, 586 of 4618 (12.68%) had a Pap smear whereas in the patients with non‑insurance, only 14 of 371 (3.7%) had it, and this difference was significant (P < 0.00001; OR 3.7, 95% IC 2.15‑6.36). Conclusions: Although Pap smear is not indicated in women with total hysterectomy, this study is still carried out frequently


Cancer; cervical cancer; hysterectomy; pap smear; screening

Full Text:



Aldaco‑Sarvide F, Pérez‑Pérez P, Cervantes‑Sánchez G,

Torrecillas‑Torres L, Erazo‑Valle‑Solís AA, Cabrera‑Galeana P,

et al. Mortality from cancer in Mexico: 2015 update. GAMO


Schiffman M, Wentzensen N. High‑Quality Risk‑based

Cervical Cancer Screening for the U.S. and the World:

A Realistic example of precision prevention. Available

from: https://deainfo.nci.nih.gov/advisory/joint/1117/04‑

SchiffmanWentzensen.pdf. [Last accessed on 2019 Nov 12].

World Health Organization. Reproductive Health,

World Health Organization. Chronic Diseases, & Health

Promotion. 2nd ed. Comprehensive cervical cancer

control: A guide to essential practice. 2014. Available from: https://apps.who.int/iris/bitstream/handle/10665/

/9789241548953_eng.pdf; jsessionid=26BDB584D4DFA

C592AAF0DA660A5F489?sequence=1. [Last accessed on 2019

Nov 12].

Granados‑García V, Flores YN, Pérez R, Rudolph SE,

Lazcano‑Ponce E, Salmerón J. Cost of the cervical cancer

screening program at the Mexican social security institute. Salud

Publica Mex 2014;56:502‑10.

Fetters MD, Lieberman RW, Abrahamse PH, Sanghvi RV,

Sonnad SS. Cost‑effectiveness of Pap smear screening for

vaginal cancer after total hysterectomy for benign disease. J Low

Genit Tract Dis 2003;7:194‑202.

Timely prevention and detection of cervical cancer in the

first level of care. México [Prevención y detección oportuna

del cáncer cérvico uterino en el primer nivel de atención.

México]: Instituto Mexicano del Seguro Social. 2010. Available

from: http://www.imss.gob.mx/profesionales/guiasclinicas

/Pages/guias.aspx. [Last accessed on 2019 Nov 12].

Shin JY, Choi KS, Suh M, Park B, Jun JK. Comparison of

cervical cancer screening among women with and without

hysterectomies: A nationwide population‑based study in Korea.

BMC Cancer 2018 11;18:810.

Teoh D, Isaksson Vogel R, Hultman G, Monu M, Downs L,

Geller MA, et al. Single health system adherence to 2012

cervical cancer screening guidelines at extremes of age and

posthysterectomy. Obstet Gynecol 2017;129:448‑56.